LS Investment Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,901
| Closed | -$8K | – | 1750 |
|
|
2019
Q4 | $8K | Hold |
1,901
| – | – | ﹤0.01% | 1685 |
|
|
2019
Q3 | $9K | Hold |
1,901
| – | – | ﹤0.01% | 1661 |
|
|
2019
Q2 | $12K | Hold |
1,901
| – | – | ﹤0.01% | 1624 |
|
|
2019
Q1 | $11K | Hold |
1,901
| – | – | ﹤0.01% | 1616 |
|
|
2018
Q4 | $26K | Buy |
1,901
+160
| +9% | +$2.7K | ﹤0.01% | 1441 |
|
|
2018
Q3 | $34K | Buy |
1,741
+163
| +10% | +$3.47K | ﹤0.01% | 1447 |
|
|
2018
Q2 | $40K | Hold |
1,578
| – | – | ﹤0.01% | 1396 |
|
|
2018
Q1 | $32K | Buy |
1,578
+116
| +8% | +$2.71K | ﹤0.01% | 1435 |
|
|
2017
Q4 | $29K | Sell |
1,462
-378
| -21% | -$7.43K | ﹤0.01% | 1470 |
|
|
2017
Q3 | $38K | Hold |
1,840
| – | – | ﹤0.01% | 1441 |
|
|
2017
Q2 | $27K | Hold |
1,840
| – | – | ﹤0.01% | 1520 |
|
|
2017
Q1 | $29K | Hold |
1,840
| – | – | ﹤0.01% | 1488 |
|
|
2016
Q4 | $23K | Hold |
1,840
| – | – | ﹤0.01% | 1524 |
|
|
2016
Q3 | $52K | Buy |
1,840
+313
| +20% | +$10.5K | ﹤0.01% | 1204 |
|
|
2016
Q2 | $53K | Buy |
1,527
+137
| +10% | +$4.31K | ﹤0.01% | 1184 |
|
|
2016
Q1 | $38K | Buy |
+1,390
| New | +$40.9K | ﹤0.01% | 1274 |
|
Other funds holding DPLO
LS Investment Advisors's DPLO Position: Q1 2020 in Review
LS Investment Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 1,901 shares — an estimated $8K sold.
LS Investment Advisors first reported a position in DPLO in Q1 2016 and held it in 16 quarters. The position peaked at $53K in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- LS Investment Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- LS Investment Advisors sold 1,901 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $8K.
- LS Investment Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 16 quarters.
- LS Investment Advisors's DIPLOMAT PHARMACY, INC. position peaked at $53K in Q2 2016.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on LS Investment Advisors's 13F filing for Q1 2020, filed 20 Apr 2020.